Scholarlink

This chapter considers the manner in which the COVID-19 pandemic changed SACT delivery across Europe. This covers the effects and uncertainties around the potential interactions between SACT and SARS-CoV-2 infection resulting in visitor restriction and reductions and curtailment of treatments as well as adaptations to SACT treatments as a response to the pandemic. The potential positive effects of these adaptations, such as a move to virtual assessment, increased deployment of granulocyte-colony-stimulating factor and a favouring of oral and sub-cut delivery and self-administration are also discussed. The chapter concludes with an analysis of the long-term impact of the COVID-19 pandemic on SACT delivery.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Delivery of Systemic Anti-Cancer Therapies (SACT) During the COVID-19 Pandemic

  • 章节

  • 出版模式：

    开放获取

  • 发表日期：

    2026年

查看全文
  • Mark Foulkes

摘要

This chapter considers the manner in which the COVID-19 pandemic changed SACT delivery across Europe. This covers the effects and uncertainties around the potential interactions between SACT and SARS-CoV-2 infection resulting in visitor restriction and reductions and curtailment of treatments as well as adaptations to SACT treatments as a response to the pandemic. The potential positive effects of these adaptations, such as a move to virtual assessment, increased deployment of granulocyte-colony-stimulating factor and a favouring of oral and sub-cut delivery and self-administration are also discussed. The chapter concludes with an analysis of the long-term impact of the COVID-19 pandemic on SACT delivery.